COL1A2 and cancer: Epigenetic changes in genes are thought to be the leading cause of neoplastic transformation [28], and hence we analyzed the promoter methylation level of COL1A2 across various clinicopathological characteristics and found the possible negative correlation with the expression profile, particularly in terms of cancer stage and nodal metastasis status.